Health
RedHill Biopharma Announces First Patient Dosed in U.S. Phase 2/3 COVID-19 Outpatient Study with RHB-107
- The U.S. Phase 2/3 study with once-daily, orally-administered RHB-107 (upamostat) evaluates treatment of patients with symptomatic COVID-19 who do not require hospitalization - the vast majority of patients - RHB-107 is a novel serine protease inhibitor targeting human cell factors involved in...
2021-02-17 20:00
4289
Onward Therapeutics Makes a Strategic Investment in EMERCell for Their NK Cell Technology for Immunotherapy
LAUSANNE, Switzerland, Feb. 17, 2021 /PRNewswire/ -- Onward Therapeutics SA (Onward) announced today the execution of a strategic investment in EMERCell SAS, Montpellier,France, a company that has developed a platform technology to produce off-the-shelf natural killer (NK) cells. The undisclosed ...
2021-02-17 13:00
1857
Launch of ESMO Virtual Plenaries Brings Rapid Access to Ground-Breaking Cancer Research
Timely presentations of trial data will accelerate transition from research to practice LUGANO, Switzerland, Feb. 17, 2021 /PRNewswire/ -- ESMO, the leading organisation for medical oncology, launches an important new service for rapidly disseminating research to accelerate the transition of res...
2021-02-17 13:00
1672
ABG Acquisition Corp. I Announces Pricing of Upsized $131 Million Initial Public Offering
NEW YORK and HONG KONG, Feb. 17, 2021 /PRNewswire/ -- ABG Acquisition Corp. I (the "Company") today announced the pricing of its initial public offering of 13,100,000 Class A ordinary shares at a price of$10.00 per share. The shares will be listed on The Nasdaq Capital Market and trade under the ...
2021-02-17 11:59
2931
Indian conglomerate, Godrej & Boyce aims to strengthen Vaccine Cold Chain across the world
Cold Chain Partner to the world's largest covid vaccination drive in India, refrigeration expert Godrej & Boyce launches 'made inIndia' ultra-low-temperature freezers (below -80°C) Offers vaccine cold chain solutions across all temperature bands MUMBAI, India, Feb. 17, 2021 /PRNewswire/ -- Godr...
2021-02-17 11:00
4861
88% Vaccination Rate Across Yas Island Employees
Abu Dhabi's leading leisure and entertainment destination to be among the first in the world to vaccinate most of itsemployees, signaling its commitment to health and safety ABU DHABI, UAE, Feb. 17, 2021 /PRNewswire/ -- Eighty-eight per cent employees working at attractions, experiences, hotels,...
2021-02-17 09:00
912
Atlas Antibodies acquires HistoCyte Laboratories, a global leader in cell line controls for histopathology
STOCKHOLM and NEWCASTLE UPON TYNE, England, Feb. 17, 2021 /PRNewswire/ -- Atlas Antibodies AB has signed an agreement to acquire UK company HistoCyte Laboratories Ltd. HistoCyte Laboratories' portfolio of innovative cell line materials provides control of immunohistochemical assays used in the di...
2021-02-17 01:20
1553
CGTN：What is China's role in global fight against COVID-19?
BEIJING, Feb. 17, 2021 /PRNewswire/ -- The COVID-19 pandemic, affecting all countries, has underscored both the wayChina addresses a global challenge and its vision for a better world.   As the first major country to have effectively contained the virus and the only major econo...
2021-02-17 00:46
3539
Becton Dickinson Lauded by Frost & Sullivan for Enhancing Patient Experience with Its BD Intevia™ Autoinjector
The solution leverages a modular platform technology that allows rapid customization, optimizing time and cost for pharma companies SANTA CLARA, Calif., Feb. 16, 2021 /PRNewswire/ -- Based on its recent analysis of the global autoinjector drug delivery market, Frost & Sullivan recognizes BD (Bec...
2021-02-16 18:00
3244
Deep Longevity Publishes Article About Preventing COVID-19 and Aging
HONG KONG, Feb. 16, 2021 /PRNewswire/ -- Regent Pacific Group Limited ("Regent Pacific" or the "Company" and together with its subsidiaries, the "Group";SEHK: 0575.HK)'s Deep Longevity, Inc, a company acquired on 14 December 2020 which develops artificial intelligence to track human aging and ext...
2021-02-16 17:20
5540
Holmusk Announces New Publication: Deep Learning-Based Natural Language Processing Models that Translate Unstructured Psychiatry Notes into Quantifiable Measures
SINGAPORE and NEW YORK, Feb. 16, 2021 /PRNewswire/ -- Holmusk, a leading global data science and digital health company building the largest Real-World Evidence (RWE) platform for behavioral health, today announced the publication of its scientific article "Natural Language Processing-Based Quant...
2021-02-16 14:00
3163
The Philippines Unveils Unique Advantages in Covid-critical PPE and Medical Supplies Manufacturing at Japanese Business Event
COST EFFICIENT, RESILIENT TALENT POOL AND STRATEGIC POLICY REFORMS PROVIDE INVESTMENT OPPORTUNITIES FORJAPAN AND NEIGHOURING MARKETS TOKYO, Feb. 16, 2021 /PRNewswire/ -- Today, the Philippine government in partnership with the Japan Hygiene Products Industry Association (JHPIA) organized an onli...
2021-02-16 13:30
4578
Onward Therapeutics and Biomunex Pharmaceuticals Enter into a Worldwide Exclusive License and Co-development Agreement to a Bispecific Antibody for Immuno-Oncology
Onward Also Makes an Equity Investment in Biomunex LAUSANNE, Switzerland, Feb. 16, 2021 /PRNewswire/ -- Onward Therapeutics SA (Onward) announced today the execution of a worldwide exclusive license and co-development agreement with Biomunex Pharmaceuticals SAS (Biomunex),Paris, France, of a b...
2021-02-16 13:00
2309
Health Tips by Infinitus Scientific Advisor: Restore the Immunity by Improving Gastrointestinal Health
HONG KONG, Feb. 16, 2021 /PRNewswire/ -- Ching-Chiung Wang ph. D., Director, Graduate Institute of Pharmacognosy, Taipei Medical University, recently provided the following health tips. Dr. Wang Ching-Chiung is the scientific advisory board member of Infinitus Health Products (International) Comp...
2021-02-16 09:00
2730
Noma Medical Crisis: African Football Legends Launch Appeal For Donations To Save "Children Without Faces"
PARIS, Feb. 16, 2021 /PRNewswire/ -- Though it affects more than 140,000 children each year, noma remains a little-known disease among the general public. Derived from the Greek word "nomein," meaning "to devour," the disease destroys the face, resulting in the death of the child in 90% of cases....
2021-02-16 09:00
4856
Menarini Silicon Biosystems announces launch of CellMag™ product line offering affordable Gold Standard Circulating Tumor Cells capture
CELLMAG – a cost effective, manual and simple approach for the enrichment and staining of extremely rare cells from blood BOLOGNA, Italy and HUNTINGDON VALLEY, Pa., Feb. 16, 2021 /PRNewswire/ -- Menarini Silicon Biosystems, a pioneer of liquid biopsy and single cell technologies, announced today...
2021-02-16 06:00
3311
Invitation to the presentation of Elekta's third quarter 2020/21
STOCKHOLM, Feb. 15, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) invites analysts and investors to a presentation of the third quarter 2020/21 at10:00 a.m. CET on February 25. The interim report for the third quarter will be published at 7:30 a.m. CET on the same day. The company's development will be...
2021-02-15 20:37
4904
Kungl. Vetenskapsakademien: New knowledge about a cancer pharmaceutical led to the Sjöberg Prize
MALMÖ, Sweden, Feb. 15, 2021 /PRNewswire/ -- Benjamin L. Ebert, USA, receives this year's Sjöberg Prize, worthone million US dollars, for his research into how lenalidomide works as a treatment for blood cancer. His discovery of the mechanism that promotes protein breakdown in cancer cells may be...
2021-02-15 20:35
2206
Futurise Inks Memorandum of Understanding (MOU) with Korea Development Institute (KDI) to Collaborate towards Knowledge Sharing and Co-research Activities
KUALA LUMPUR, Malaysia, Feb. 15, 2021 /PRNewswire/ -- Futurise Sdn Bhd (Futurise) today announced the cooperation and collaborative efforts with Korea Development Institute (KDI) towards promoting knowledge sharing and to pursue co-research activities on key areas of common interests. The collabo...
2021-02-15 14:06
4223
TCAI leader participates in clinical trial for catheter that may prevent rare, life-threatening complication during cardiac ablation
AUSTIN, Texas, Feb. 15, 2021 /PRNewswire/ -- A physician with the Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center is among the first in the world to participate in a clinical trial to evaluate the safety and efficacy of a new cardiac-specific catheter used during pulsed fi...
2021-02-15 11:08
4471
Week's Top Stories
Most Reposted
Senetas and Nokia Announce Strategic Alliance to Secure Mission-Critical Networks for Defence and Government
[Picked up by 312 media titles]
2025-11-27 07:25World-Leading Microsurgeon Professor J.P. Hong Joins MediThinQ as CMO, Marking Strong Validation for Next-Generation Digital Microsurgery
[Picked up by 297 media titles]
2025-12-03 09:00
SpeQtre, the entanglement-based quantum comms demonstrator satellite, is now on orbit
[Picked up by 295 media titles]
2025-11-29 09:00
Blackpanda and ST Engineering Partner to Strengthen Cyber Incident Response Across Asia
[Picked up by 288 media titles]
2025-12-03 14:27
MetaOptics Announces Strategic Share Placement to Accelerate Growth and Meet Rising Global Demand
[Picked up by 284 media titles]
2025-12-01 08:30Most Read
MINISO Unveils Australia's First and Largest MINISO LAND Flagship at Sydney Chatswood
2025-11-27 18:56
2916
